Astrazeneca Pharma India Ltd vs Veerhealth Care Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Astrazeneca Pharma India Ltd is ₹ 8530 as of 18 May 15:29 . The P/E Ratio of Astrazeneca Pharma India Ltd changed from 80.7 on March 2021 to 185.9 on March 2025 . This represents a CAGR of 18.16% over 5 yearsThe P/E Ratio of Veerhealth Care Ltd changed from 13.8 on March 2021 to 61.2 on March 2025 . This represents a CAGR of 34.70% over 5 years The Market Cap of Astrazeneca Pharma India Ltd changed from ₹ 7525 crore on March 2021 to ₹ 21515 crore on March 2025 . This represents a CAGR of 23.38% over 5 yearsThe Market Cap of Veerhealth Care Ltd changed from ₹ 5.27 crore on March 2021 to ₹ 24.48 crore on March 2025 . This represents a CAGR of 35.96% over 5 years The revenue of Astrazeneca Pharma India Ltd for the Dec '25 is ₹ 618.18 crore as compare to the Sep '25 revenue of ₹ 565.26 crore. This represent the growth of 9.36% The revenue of Veerhealth Care Ltd for the Dec '25 is ₹ 6.97 crore as compare to the Sep '25 revenue of ₹ 4.21 crore. This represent the growth of 65.56% The ebitda of Astrazeneca Pharma India Ltd for the Dec '25 is ₹ 51.44 crore as compare to the Sep '25 ebitda of ₹ 76.06 crore. This represent the decline of -32.37% The ebitda of Veerhealth Care Ltd for the Dec '25 is ₹ 0.94 crore as compare to the Sep '25 ebitda of ₹ 0.76 crore. This represent the growth of 23.68% The net profit of Astrazeneca Pharma India Ltd changed from ₹ -11.79 crore to ₹ 32.59 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Veerhealth Care Ltd changed from ₹ 0.12 crore to ₹ 0.4 crore over 7 quarters. This represents a CAGR of 98.97% The Dividend Payout of Astrazeneca Pharma India Ltd changed from 5.36 % on March 2021 to 69.12 % on March 2025 . This represents a CAGR of 66.76% over 5 yearsThe Dividend Payout of Veerhealth Care Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Astrazeneca Pharma India Ltd

AstraZeneca Pharma India Limited (APIL) was incorporated on July 11, 1979.
The Company is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and co-ordinates clinical trial services with an overseas group company.
The major therapy areas where the company operates are Onocology, Alimentary & Metabolism, Cardio Vascular, Renal, Diabetes, Respiratory and Oncology. AstraZeneca Pharma India, formerly known as Astra-IDL (AIL), was an erstwhile joint venture of Astra Zeneca, UK and Hinduja controlled IDL. Astra Pharmaceuticals AB, Sweden acquired all of the 1287500 equity shares in the Company of IDL, representing 25.75% of the Company's issued and paid up equity share capital.
Consequently, the Company became a subsidiary of Astra, which is a direct wholly owned subsidiary of Astra AB, Sweden (now known as AstraZeneca Pharmaceuticals AB Sweden) and an indirect wholly owned subsidiary of AstraZeneca Plc, the Group parent Company.

About Veerhealth Care Ltd

Veerhealth Care Limited was originally incorporated on 10 July, 1992 as Niyati Leasing Limited to start business in Investment and Finance.
The main objects of the Company in 1998 got changed and accordingly the name of the Company was changed from Niyati Leasing Limited to Niyati Industries Limited and again to Veerhealth Care Limited in May, 2013. Initially in 2010, the Company was engaged into dealing and trading of shares, securities, debentures, and other investments.
It wanted to start business in the field of infrastructure.
Later on, the Company through the Main Objects, diversify the business activities to Pharma sector in 2013.
Apart from Tablet, Syrup, Ointment, Powder, it also started manufacturing in the Oil, Shampoo, Ointment and Toothpaste Division in 2015-16.

FAQs for the comparison of Astrazeneca Pharma India Ltd and Veerhealth Care Ltd

Which company has a larger market capitalization, Astrazeneca Pharma India Ltd or Veerhealth Care Ltd?

Market cap of Astrazeneca Pharma India Ltd is 21,221 Cr while Market cap of Veerhealth Care Ltd is 44 Cr

What are the key factors driving the stock performance of Astrazeneca Pharma India Ltd and Veerhealth Care Ltd?

The stock performance of Astrazeneca Pharma India Ltd and Veerhealth Care Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Astrazeneca Pharma India Ltd and Veerhealth Care Ltd?

As of May 18, 2026, the Astrazeneca Pharma India Ltd stock price is INR ₹8488.45. On the other hand, Veerhealth Care Ltd stock price is INR ₹22.44.

How do dividend payouts of Astrazeneca Pharma India Ltd and Veerhealth Care Ltd compare?

To compare the dividend payouts of Astrazeneca Pharma India Ltd and Veerhealth Care Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.